Storage Condition
Store at refrigerator (2-8°C) for long term storage
Synonyms
(R)-4-(Ethylamino)-2-(3-methoxypropyl)-3,4-dihydro-2H-thieno[3,2-e][1,2]thiazine-6-sulfonamide 1,1-dioxide hydrochloride d5
Application Notes
Useful research chemical for a range of applications
Hazard Compound
No -Refer MSDS for accurate information
Brinzolamide-d5 Hydrochloride is a drug product that is used as an analytical standard for HPLC, as well as in research and development of drugs.
Refund Policy
We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in
place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of
material handover.
We have invested in the highest quality packaging materials and use international logistics partners to service our customers. While all
possible precautions have been taken to deliver the required product(s), there may be some rare situations when our product does not
meet your requirements. Should that arise, please contact us with your concerns and we will endeavour to address them on a priority
basis. If there is no other option, we will either replace your product(s) or issue a refund or account credit, whichever you prefer.
If there is an issue with one or more of our products, our policy is that it must be reported to us within 45 days of your receiving shipment.
While we will always address product issues after the 45 day return window has passed, we cannot issue a refund or account credit. As
always, we appreciate your support.
Brinzolamide-d5 Hydrochloride usage and description
Brinzolamide D5 Hydrochloride is a medication primarily used for the treatment of open-angle glaucoma and ocular hypertension. It belongs to the class of drugs known as carbonic anhydrase inhibitors, which work by reducing the production of aqueous humor in the eye, thereby lowering the intraocular pressure.
Chemically, Brinzolamide D5 Hydrochloride is a deuterated derivative of brinzolamide, with five deuterium atoms replacing the hydrogen atoms in the molecule. The deuterated form of the drug has a longer half-life and improved pharmacokinetic properties compared to its non-deuterated counterpart.
The medication is administered as eye drops, with the recommended dosage being one drop in the affected eye(s) twice daily. It is important to follow the dosing instructions provided by the healthcare provider to ensure maximum effectiveness and avoid the risk of adverse effects.
Brinzolamide D5 Hydrochloride has been extensively studied for its safety and efficacy in clinical trials. It has been found to be well-tolerated by most patients, with the most common side effects being ocular discomfort, blurred vision, and a bitter taste in the mouth.
In conclusion, Brinzolamide D5 Hydrochloride is a valuable medication for the management of open-angle glaucoma and ocular hypertension. Its deuterated form offers improved pharmacokinetics, making it a preferred choice for many healthcare providers.
